Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06152276 · ClinicalTrials.gov registry record
SafeHeal Diverting Ileostomy Pivotal Study
A clinical trial of Colorectal Cancer and Stoma Ileostomy, sponsored by SafeHeal.
- Active
- Registry status
- 132
- Enrollment target
- 3
- Study locations
NCT06152276 is a study of Colorectal Cancer and Stoma Ileostomy that is active but no longer recruiting, run by SafeHeal. The registered enrollment target is 132 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06152276, a study of Colorectal Cancer and Stoma Ileostomy, is active but no longer recruiting, sponsored by SafeHeal.
- ACTIVE NOT RECRUITING
- Registry status
- 132 participants
- Enrollment target
- 3
- Study locations
Study Summary
This SafeHeal study is designed to assess the overall safety of the low anterior resection (LAR) standard of care cancer treatment by establishing a definition of major complications. The current literature on standard of care reports adverse events/complications but does not provide a single endpoint that can be used to compare the safety of LAR cancer treatment to alternative therapies or treatments. This study will allow for the establishment of a new single safety endpoint for LAR standard of care cancer treatment.
Conditions Studied
Interventions
- OTHER Diverting loop ileostomy
Study Locations (3)
New York
- Maimonides Medical Center - Brooklyn
- Lenox Hill Hospital - New York
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06152276
The ClinicalTrials.gov registry entry for NCT06152276 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (91% lower). The listed sponsor is SafeHeal, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Diverting loop ileostomy is the first listed.
NCT06152276 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06152276 about?
NCT06152276 is a clinical study titled "SafeHeal Diverting Ileostomy Pivotal Study". This SafeHeal study is designed to assess the overall safety of the low anterior resection (LAR) standard of care cancer treatment by establishing a definition of major complications. The current literature on standard of care reports adverse events/complications but does not provide a single endpoi...
What is the current status of trial NCT06152276?
This trial is currently active not recruiting. The enrollment target is 132 participants. The study started on 2024-01-01. Estimated completion is 2026-03.
What conditions does trial NCT06152276 study?
This clinical trial studies the following conditions: Colorectal Cancer, Stoma Ileostomy.
What interventions are being tested in trial NCT06152276?
The interventions under investigation include: Diverting loop ileostomy (OTHER).
Who is sponsoring clinical trial NCT06152276?
This trial is sponsored by SafeHeal, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06152276 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.